Michael Douglas Taylor, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 41,000 shares at $39.47 ($1.7M) on 2019-08-13, disclosed to the SEC on 2019-08-13.
Open-market sale of $1.7M DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.47 | 3,433 | $136K | 8.1% |
| 2 | $39.47 | 3,433 | $136K | 8.1% |
| 3 | $40.50 | 13,767 | $558K | 33.5% |
| 4 | $40.50 | 13,767 | $558K | 33.5% |
| 5 | $41.77 | 1,300 | $54K | 3.3% |
| 6 | $41.77 | 1,300 |
| $54K |
| 3.3% |
| 7 | $42.49 | 4,000 | $170K | 10.2% |
| Total | $40.60 avg | 41,000 | $1.7M | 100% |
| Filing → |
| DCPH | SELL | 2021-03-03 | $655K | — | Filing → |
| DCPH | SELL | 2021-02-03 | $687K | — | Filing → |
| DCPH | SELL | 2021-01-06 | $2.1M | — | Filing → |